← Leaderboards
Richard Thomas Wyatt
Scripps Research Institute, The
$25,384,171
Attributed
$25,384,171
Total exposure
20
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.8M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,310,092 · 22
By mechanism
P01$54,043,400 · 21
R01$3,266,692 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Andrew Barrett Ward$14,394,344
- Jiang Zhu$14,887,050
- Michael B Zwick$21,835,418
- David Nemazee$50,518,228
- Ian A Wilson$64,513,205
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyAntigensResponseDesignStructureB-LymphocytesAntibodiesGlycoproteinsHiv Envelope Protein Gp120VaccinesHiv-1BaseEpitopesAnimalsNonhuman PrimateImmunogenicityBinding SitesAffinityResolutionImmunizationPolysaccharidesOryctolagus CuniculusProteinsCollaborations
Grant awards (75)
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$2,794,109
P01 · FY2025 · AI · contact PI
Project-001$558,822
P01 · FY2025 · AI · contact PI
Core-002$558,822
P01 · FY2025 · AI · contact PI
Core-001$558,822
P01 · FY2025 · AI · contact PI
Admin-Core-001$558,822
P01 · FY2025 · AI · contact PI
Project-002$558,821
P01 · FY2025 · AI · contact PI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$3,442,683
P01 · FY2024 · AI · contact PI
Core-001$1,328,117
P01 · FY2024 · AI · contact PI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$976,445
P01 · FY2024 · AI · contact PI
Core-002$928,096
P01 · FY2024 · AI · contact PI
Core-002$739,446
P01 · FY2024 · AI · contact PI
Project-002$674,912
P01 · FY2024 · AI · contact PI
Admin-Core-001$511,558
P01 · FY2024 · AI · contact PI
Project-001$236,999
P01 · FY2024 · AI · contact PI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$3,402,658
P01 · FY2023 · AI · contact PI
Core-001$1,396,395
P01 · FY2023 · AI · contact PI
Core-002$1,130,492
P01 · FY2023 · AI · contact PI
N-glycan baiting to target the highly effective HIV Env shield$961,798
R01 · FY2023 · AI · contact PI
Project-002$503,260
P01 · FY2023 · AI · contact PI
Admin-Core-001$372,511
P01 · FY2023 · AI · contact PI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$3,420,035
P01 · FY2022 · AI · contact PI
Project 1$1,155,919
P01 · FY2022 · AI · contact PI
Admin Core$214,021
P01 · FY2022 · AI · contact PI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates$3,242,006
P01 · FY2021 · AI · contact PI
Project 1$1,264,760
P01 · FY2021 · AI · contact PI
N-glycan baiting to target the highly effective HIV Env shield$961,798
R01 · FY2021 · AI · contact PI
Admin Core$214,021
P01 · FY2021 · AI · contact PI
N-glycan baiting to target the highly effective HIV Env shield$671,548
R01 · FY2020 · AI · contact PI
Design of subtype C NFL trimers for virus-like particle array$364,402
P01 · FY2020 · AI · contact PI
N-glycan baiting to target the highly effective HIV Env shield$671,548
R01 · FY2019 · AI · contact PI
Design of subtype C NFL trimers for virus-like particle array$364,357
P01 · FY2019 · AI · contact PI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design$2,676,775
P01 · FY2018 · AI · contact PI
Immunogen Design and Selection$1,603,771
P01 · FY2018 · AI · contact PI
Design of subtype C NFL trimers for virus-like particle array$361,814
P01 · FY2018 · AI · contact PI
Administrative Core$155,082
P01 · FY2018 · AI · contact PI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design$2,659,329
P01 · FY2017 · AI · contact PI
Immunogen Design and Selection$1,234,493
P01 · FY2017 · AI · contact PI
Design of subtype C NFL trimers for virus-like particle array$364,813
P01 · FY2017 · AI · contact PI
Administrative Core$145,990
P01 · FY2017 · AI · contact PI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design$3,841,632
P01 · FY2016 · AI · contact PI
Immunogen Design and Selection$1,904,135
P01 · FY2016 · AI · contact PI
Design of subtype C NFL trimers for virus-like particle array$285,757
P01 · FY2016 · AI · contact PI
Administrative Core$103,514
P01 · FY2016 · AI · contact PI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design$2,810,461
P01 · FY2015 · AI · contact PI
Immunogen Design and Selection$726,458
P01 · FY2015 · AI · contact PI
Administrative Core$102,741
P01 · FY2015 · AI · contact PI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design$2,659,788
P01 · FY2014 · AI · contact PI
Immunogen Design and Selection$822,960
P01 · FY2014 · AI · contact PI
Administrative Core$112,576
P01 · FY2014 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$540,092
ZIA · FY2009 · AI · contact PI
Immmunogenicity and Structure of trimeric HIV-1 gp120 glycoproteins$540,091
ZIA · FY2009 · AI · contact PI
Structure and Immunogenicity of HIV-1 gp41 Membrane Proximal Region (MPR)$540,091
ZIA · FY2009 · AI · contact PI
Biophysics, Structure and Immunogenicity of Stabilized HIV-1 Env glycoproteins$169,606
ZIA · FY2009 · AI · contact PI
Immmunogenicity and Structure of HIV-1 gp140 glycoproteins$169,604
ZIA · FY2009 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$579,944
Z01 · FY2008 · AI · contact PI
Structure and Immunogenicity of HIV-1 gp41 Membrane Proximal Region (MPR)$469,750
Z01 · FY2008 · AI · contact PI
Production And Characterization Of HIV-1 Solid Phase Proteoliposomes$414,653
Z01 · FY2008 · AI · contact PI
Biophysics, Structure and Immunogenicity of Stabilized HIV-1 Env glycoproteins$308,730
Z01 · FY2008 · AI · contact PI
Immmunogenicity and Structure of HIV-1 gp140 glycoproteins$308,730
Z01 · FY2008 · AI · contact PI
Immmunogenicity and Structure of trimeric HIV-1 gp120 glycoproteins$194,265
Z01 · FY2008 · AI · contact PI
Production And Characterization Of HIV-1 Solid Phase Proteoliposomes$191,595
Z01 · FY2007 · AI · contact PI
Epitope Mapping of Neutralizing Antibody Responses$191,595
Z01 · FY2007 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$191,595
Z01 · FY2007 · AI · contact PI
Structure and Immunogenicity of HIV-1 gp41 Membrane Proximal Region (MPR)$191,193
Z01 · FY2007 · AI · contact PI
Structure and Immunogenicity of HIV-1 gp41 Membrane Prox$0
Z01 · FY2006 · AI · contact PI
Determination of the Neutralization Specificity in Broad$0
Z01 · FY2006 · AI · contact PI
Production And Characterization Of HIV-1 Solid Phase Pro$0
Z01 · FY2006 · AI · contact PI
Immmunogenicity and Structure of trimeric HIV-1 gp120 gl$0
Z01 · FY2005 · AI
Structure and Immunogenicity of HIV-1 gp41 Membrane$0
Z01 · FY2005 · AI
Biophysics /Structure /Immunogenicity of HIV-1Glycoprote$0
Z01 · FY2005 · AI
Immmunogenicity and Structure of HIV-1 gp140 glycoprotei$0
Z01 · FY2005 · AI
HIV-1 Solid Phase Proteoliposome$0
Z01 · FY2005 · AI
Immmunogenicity and Structure of trimeric HIV-1 gp120$0
Z01 · FY2004 · AI
Immunogenicity and Structure of HIV-1 gp140 glycoprotei$0
Z01 · FY2004 · AI
Production And Characterization Of HIV-1 Proteoliposomes$0
Z01 · FY2004 · AI